Literature DB >> 3179550

Graphical aid for determining power of clinical trials involving two groups.

D K Miller1, S M Homan.   

Abstract

Physicians need to evaluate clinical research critically, and determining the power of a study is an essential component of research evaluation. This report presents a graphical aid that permits rapid power determination for clinical trials with two groups. Power curves were developed for dichotomous outcomes by setting two tail alpha at 0.05 and varying the sample size, the control group response rate, and the clinically important difference between control and experimental groups as defined by the user. Use of the graphical aid was demonstrated to a group of 18 medical students, residents, fellows, and faculty in a 15 minute session. Evaluation of the trainees' application of the aid showed a small average bias of -0.0003 and an average variance of 0.006. Ninety percent of power estimates were within 0.05 of the true value determined by formula. This graphical aid is recommended as a rapid and accurate method for determining power in the critical appraisal of clinical research.

Entities:  

Mesh:

Year:  1988        PMID: 3179550      PMCID: PMC1834346          DOI: 10.1136/bmj.297.6649.672

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  18 in total

1.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

2.  Effect of sodium amylosulfate (Depepsen) on the healing of duodenal ulcer.

Authors:  K D Landecker; E M McCallum; D I Fevre; R Green; A Kasumi; D W Piper
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

Review 3.  Transient ischemic attacks and aspirin, stroke and death; negative studies and Type II error.

Authors:  M L Dyken
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

4.  A new series on biostatistics.

Authors:  A S Relman
Journal:  N Engl J Med       Date:  1982-06-03       Impact factor: 91.245

5.  Reporting on methods in clinical trials.

Authors:  R DerSimonian; L J Charette; B McPeek; F Mosteller
Journal:  N Engl J Med       Date:  1982-06-03       Impact factor: 91.245

6.  Statistical proof in inconclusive 'negative' trials.

Authors:  J F Reed; W Slaichert
Journal:  Arch Intern Med       Date:  1981-09

7.  Introduction to sample size determination and power analysis for clinical trials.

Authors:  J M Lachin
Journal:  Control Clin Trials       Date:  1981-06

8.  Statistics and ethics in medical research: III How large a sample?

Authors:  D G Altman
Journal:  Br Med J       Date:  1980-11-15

9.  Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.

Authors:  P S Sorensen; H Pedersen; J Marquardsen; H Petersson; A Heltberg; N Simonsen; O Munck; L A Andersen
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

10.  Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.

Authors:  M L Simoons; A E Arnold; A Betriu; D P de Bono; J Col; F C Dougherty; R von Essen; H Lambertz; J Lubsen; B Meier
Journal:  Lancet       Date:  1988-01-30       Impact factor: 79.321

View more
  4 in total

1.  Sample size and power for comparing two or more treatment groups in clinical trials.

Authors:  S J Day; D F Graham
Journal:  BMJ       Date:  1989-09-09

2.  Hope for broken hips.

Authors:  R J Simpson; N H Whitaker
Journal:  BMJ       Date:  1988-12-10

Review 3.  [Risk of pregnancy complications associated with residency].

Authors:  L Ménard; R Gagnon
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

Review 4.  Sample size for beginners.

Authors:  C D Florey
Journal:  BMJ       Date:  1993-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.